Geode Capital Management, LLC Nektar Therapeutics Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,963,083 shares of NKTR stock, worth $4.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,963,083
Previous 4,112,499 3.63%
Holding current value
$4.24 Million
Previous $5.1 Million 1.04%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1.11 - $1.48 $165,851 - $221,135
-149,416 Reduced 3.63%
3,963,083 $5.15 Million
Q2 2024

Aug 09, 2024
BUY
$0.9 - $1.83 $1.85 Million - $3.77 Million
2,059,414 Added 100.31%
4,112,499 $5.1 Million
Q1 2024

May 13, 2024
BUY
$0.49 - $0.96 $6,600 - $12,932
13,471 Added 0.66%
2,053,085 $1.91 Million
Q4 2023

Feb 13, 2024
BUY
$0.42 - $0.57 $35,388 - $48,027
84,258 Added 4.31%
2,039,614 $1.14 Million
Q3 2023

Nov 13, 2023
BUY
$0.51 - $1.05 $30,284 - $62,351
59,382 Added 3.13%
1,955,356 $1.17 Million
Q2 2023

Aug 11, 2023
SELL
$0.53 - $1.03 $859,714 - $1.67 Million
-1,622,102 Reduced 46.11%
1,895,974 $1.1 Million
Q1 2023

May 15, 2023
BUY
$0.64 - $3.15 $47,593 - $234,249
74,365 Added 2.16%
3,518,076 $2.46 Million
Q4 2022

Feb 13, 2023
BUY
$2.03 - $4.28 $238,973 - $503,845
117,721 Added 3.54%
3,443,711 $7.78 Million
Q3 2022

Nov 14, 2022
BUY
$3.04 - $5.14 $218,962 - $370,218
72,027 Added 2.21%
3,325,990 $10.6 Million
Q2 2022

Aug 12, 2022
BUY
$3.17 - $6.17 $2.54 Million - $4.94 Million
800,499 Added 32.63%
3,253,963 $12.4 Million
Q1 2022

May 13, 2022
BUY
$4.16 - $13.72 $398,573 - $1.31 Million
95,811 Added 4.06%
2,453,464 $13.2 Million
Q4 2021

Feb 11, 2022
SELL
$10.83 - $18.41 $34,287 - $58,286
-3,166 Reduced 0.13%
2,357,653 $31.9 Million
Q3 2021

Nov 12, 2021
SELL
$13.07 - $18.84 $370,024 - $533,379
-28,311 Reduced 1.18%
2,360,819 $42.4 Million
Q2 2021

Aug 13, 2021
BUY
$16.52 - $20.4 $1.03 Million - $1.27 Million
62,401 Added 2.68%
2,389,130 $41 Million
Q1 2021

May 12, 2021
BUY
$16.56 - $25.46 $678,181 - $1.04 Million
40,953 Added 1.79%
2,326,729 $46.5 Million
Q4 2020

Feb 12, 2021
BUY
$15.77 - $19.03 $3.18 Million - $3.83 Million
201,442 Added 9.66%
2,285,776 $38.9 Million
Q3 2020

Nov 13, 2020
SELL
$16.59 - $24.79 $1.22 Million - $1.83 Million
-73,798 Reduced 3.42%
2,084,334 $34.6 Million
Q2 2020

Aug 13, 2020
BUY
$16.86 - $23.44 $791,745 - $1.1 Million
46,960 Added 2.22%
2,158,132 $50 Million
Q1 2020

May 14, 2020
BUY
$14.47 - $27.96 $1.03 Million - $2 Million
71,526 Added 3.51%
2,111,172 $37.7 Million
Q4 2019

Feb 13, 2020
SELL
$15.87 - $23.12 $12.3 Million - $17.9 Million
-775,226 Reduced 27.54%
2,039,646 $44 Million
Q3 2019

Nov 12, 2019
BUY
$16.91 - $36.27 $1.58 Million - $3.39 Million
93,359 Added 3.43%
2,814,872 $51.2 Million
Q2 2019

Aug 14, 2019
BUY
$31.0 - $36.3 $10 Million - $11.7 Million
323,432 Added 13.49%
2,721,513 $96.7 Million
Q1 2019

May 14, 2019
BUY
$31.58 - $46.35 $5.18 Million - $7.6 Million
163,885 Added 7.34%
2,398,081 $80.4 Million
Q4 2018

Feb 13, 2019
BUY
$30.43 - $56.65 $156,957 - $292,200
5,158 Added 0.23%
2,234,196 $73.3 Million
Q3 2018

Nov 13, 2018
BUY
$46.46 - $68.49 $13.1 Million - $19.3 Million
281,776 Added 14.47%
2,229,038 $136 Million
Q2 2018

Aug 14, 2018
SELL
$46.25 - $104.45 $4.4 Million - $9.93 Million
-95,097 Reduced 4.66%
1,947,262 $94.9 Million
Q1 2018

May 15, 2018
BUY
$57.4 - $108.44 $34.2 Million - $64.7 Million
596,388 Added 41.24%
2,042,359 $217 Million
Q4 2017

Feb 13, 2018
BUY
$23.02 - $60.5 $321,313 - $844,459
13,958 Added 0.97%
1,445,971 $86.4 Million
Q3 2017

Nov 14, 2017
BUY
$17.79 - $24.0 $918,960 - $1.24 Million
51,656 Added 3.74%
1,432,013 $34.4 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,380,357
1,380,357 $27 Million

Others Institutions Holding NKTR

# of Institutions
147
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $201M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email